These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 522924

  • 1. Combined therapy of L1210 leukemia with Damvar and cytostatics.
    Pujman V, Cernochová S.
    Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
    [Abstract] [Full Text] [Related]

  • 2. Combined therapy of leukemia La with Damvar and cytostatics.
    Pujman V, Cernochová S.
    Neoplasma; 1979; 26(1):85-8. PubMed ID: 431759
    [Abstract] [Full Text] [Related]

  • 3. Single versus combination chemotherapy of L1210 leukemia.
    Koza I, Balázová E, Ujházy V.
    Neoplasma; 1980; 27(6):691-6. PubMed ID: 7254424
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
    Kline I, Gang M, Tyrer DD, Venditti JM, Artis EW, Goldin A.
    Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
    [No Abstract] [Full Text] [Related]

  • 5. Characteristics and response to certain cancer chemotherapeutic agents of an acute lymphocytic leukemia arising in a BALB-c times DBA-2F1 mouse.
    Yancey ST, Bleyer WA.
    Cancer Res; 1974 Aug; 34(8):1866-9. PubMed ID: 4526157
    [No Abstract] [Full Text] [Related]

  • 6. Synergistic effects of bis(3-methylsulfonyloxypropyl)-amine toluenesulfonate (864-T) with 6-mercaptopurine and other antitumor agents.
    Imamura H, Ikegami K, Okumoto T.
    Gan; 1973 Oct; 64(5):427-31. PubMed ID: 4358730
    [No Abstract] [Full Text] [Related]

  • 7. Rationale of chemotherapeutic adjuvant treatment.
    Goldin A.
    Arch Geschwulstforsch; 1978 Oct; 48(7):627-35. PubMed ID: 736743
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim.
    Stoychkov JN, Milushev AS, Todorov DK.
    Neoplasma; 1980 Oct; 27(1):33-6. PubMed ID: 6892839
    [Abstract] [Full Text] [Related]

  • 12. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
    Pouillart P, Huong TH, Lhéritier J.
    Bull Cancer; 1974 Oct; 61(4):509-26. PubMed ID: 4458834
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antitumor activity of pyrimidinones, a class of small-molecule biological response modifiers.
    Li LH, Wallace TL, Wierenga W, Skulnick HI, DeKoning TF.
    J Biol Response Mod; 1987 Feb; 6(1):44-55. PubMed ID: 3559628
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice.
    Warzocha K, Robak T.
    Acta Haematol Pol; 1992 Feb; 23(1):55-62. PubMed ID: 1615753
    [Abstract] [Full Text] [Related]

  • 17. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia.
    Schmid FA, Hutchison DJ, Otter GM, Stock CC.
    Cancer Treat Rep; 1976 Jan; 60(1):23-7. PubMed ID: 1000516
    [Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy in sequence for the treatment of L1210 leukemia.
    Roberts D, Hilliard SL.
    Cancer Res; 1978 Aug; 38(8):2317-20. PubMed ID: 667827
    [No Abstract] [Full Text] [Related]

  • 19. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
    Fujimoto S, Ogawa M, Sakurai Y.
    Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
    [No Abstract] [Full Text] [Related]

  • 20. Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.
    Burns ER, Scheving LE.
    Chronobiologia; 1980 Oct; 7(1):41-51. PubMed ID: 7438892
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.